EW
LMAT icon

Evoke Wealth’s LeMaitre Vascular LMAT Stock Holding History

Evoke Wealth’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-161
Closed -$5.79K – 1261
2019
Q4 		$5.79K Hold
161
– – ﹤0.01% 878
2019
Q3 		$5.5K Buy
+161
New +$5.14K ﹤0.01% 978

Other funds holding LMAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Evoke Wealth's LMAT Position: Q1 2020 in Review

Evoke Wealth sold out of LeMaitre Vascular (LMAT) in Q1 2020, closing a stake of 161 shares — an estimated $5.79K sold.

Evoke Wealth first reported a position in LMAT in Q3 2019 and held it in 2 quarters. The position peaked at $5.79K in Q4 2019. 144 funds tracked by Wall St. Rank hold LMAT as of Q1 2020.

  • Evoke Wealth reported no remaining LeMaitre Vascular position as of Q1 2020 after selling out during the quarter.
  • Evoke Wealth sold 161 LeMaitre Vascular shares in Q1 2020, an estimated $5.79K.
  • Evoke Wealth first reported a position in LeMaitre Vascular in Q3 2019 and held it in 2 quarters.
  • Evoke Wealth's LeMaitre Vascular position peaked at $5.79K in Q4 2019.
  • 144 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2020.

Based on Evoke Wealth's 13F filing for Q1 2020, filed 7 May 2020.